E. Klumper

In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia

E. Klumper, Rob Pieters, DR Huismans et al. · Blood · 1995 · 218 citations · Full text

Medicine, Pediatrics, Pharmacology +14

Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)

Aurélien Marabelle, Robert Hans Ingemar Andtbacka, Kevin J. Harrington et al. · Annals of Oncology · 2018 · 211 citations · Full text

Medicine, Immunology, Oncology +16

Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-beta-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia.

G.J. Schuurhuis, H J Broxterman, GJ Ossenkoppele et al. · PubMed · 1995 · 79 citations

Medicine, Oncology, Pharmacology +14

<i>IN VITRO</i> RESISTANCE TO CYTOSINE ARABINOSIDE, NOT TO DAUNORUBICIN, IS ASSOCIATED WITH THE RISK OF RELAPSE IN <i>DE NOVO</i> ACUTE MYELOID LEUKAEMIA

E. Klumper, Gert J. Ossenkoppele, Rob Pieters et al. · British Journal of Haematology · 1996 · 55 citations

Medicine, Oncology, Pharmacology +16

In vitro chemosensitivity assessed with the MTT assay in childhood acute non-lymphoblastic leukemia.

E. Klumper, Rob Pieters, Gertjan J.L. Kaspers et al. · PubMed · 1995 · 55 citations

Medicine, Oncology, Pharmacology +6